Abstract:New findings: What is the topic of this review? The role of the gut microbiome in physiology and how it can be targeted as an effective strategy against two of the most important global medical challenges of our time, namely, metabolic diseases and antibacterial resistance. What advances does it highlight? The critical roles of the microbiome in regulating host physiology and how microbiome analysis is useful for disease stratification to enable informed clinical decisions and develop interventions such as faecal microbiota transplantation, prebiotics and probiotics. Also, the limitations of microbiome modulation, including the potential for probiotics to enhance antimicrobial resistance gene reservoirs, and that currently a 'healthy microbiome' that can be used as a biobank for transplantation is yet to be defined. Abstract: The human gut microbiome is a key factor in the development of metabolic diseases and antimicrobial resistance, which are among the greatest global medical challenges of the 21st century. A recent symposium aimed to highlight state-of-the-art evidence for the role of the gut microbiome in physiology, from childhood to adulthood, and the impact this has on global disease outcomes, ageing and antimicrobial resistance. Although the gut microbiome is established early in life, over time the microbiome and its components including metabolites can become perturbed due to changes such as dietary habits, use of antibiotics and age. As gut microbial metabolites, including short-chain fatty acids, secondary bile acids and trimethylamine-N-oxide, can interact with host receptors including G protein-coupled receptors and can alter host metabolic fluxes, they can significantly affect physiological homoeostasis leading to metabolic diseases. These metabolites can be used to stratify disease phenotypes such as irritable bowel syndrome and adverse events after heart failure and allow informed decisions on clinical management and treatment. While strategies such as use of probiotics, prebiotics and faecal microbiota transplantation have been proposed as interventions to treat and prevent metabolic diseases and antimicrobial resistance, caution must be exercised, first due to the potential of probiotics to enhance antimicrobial resistance gene reservoirs, and second, a 'healthy gut microbiome' that can be used as a biobank for transplantation is yet to be defined. We highlight that sampling other parts of the gastrointestinal tract may produce more representative data than the faecal microbiome alone.

Global chemical effects of the microbiome include new bile-acid conjugations

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

The Gut Microbial Bile Acid Modulation and its Relevance to Digestive Health and Diseases

The Gut Microbiota Modulates Host Amino Acid and Glutathione Metabolism in Mice.

The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention

Metabolite interactions between host and microbiota during health and disease: Which feeds the other?

Colonic bacterial metabolites and human health

Microbial metabolites: cause or consequence in gastrointestinal disease?

Symbiotic gut microbes modulate human metabolic phenotypes

Antibiotic‐Induced Gut Microbiota Dysbiosis Modulates Host Transcriptome and m6A Epitranscriptome via Bile Acid Metabolism

Bile acid metabolism and signaling, the microbiota, and metabolic disease

Chemical transformation of xenobiotics by the human gut microbiota

Emerging chemophysiological diversity of gut microbiota metabolites

Gut microbiota-generated metabolites: missing puzzles to hosts' health, diseases, and aging

Microbiomes in physiology: insights into 21st-century global medical challenges

Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles

Chemical mixture effects on the simplified human intestinal microbiota: Assessing xenobiotics at environmentally realistic concentrations

The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs

Microbiome-derived metabolite effects on intestinal barrier integrity and immune cell response to infection

Chemoproteomic Profiling of Gut Microbiota-Associated Bile Salt Hydrolase Activity

How bile acids and the microbiota interact to shape host immunity